img

Global Cephalosporin Intermediates Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cephalosporin Intermediates Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Cephalosporin intermediates are some chemical raw materials or chemical products used in the synthesis process of cephalosporin drugs. They do not need to be produced in accordance with drug regulations and apply for batch numbers, benefiting from the steady development of the downstream antibiotic industry.
Cephalosporin Intermediates report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cephalosporin Intermediates market is projected to reach US$ 19240 million in 2029, increasing from US$ 13400 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2029. Demand from Ceftazidime and Ceftriaxone are the major drivers for the industry.
Antibiotic intermediates belong to the category of pharmaceutical intermediates. Pharmaceutical intermediates are some chemical raw materials or chemical products used in the process of drug synthesis. They are key starting materials for the production of chemical raw materials. As an important part of fine chemicals, pharmaceutical intermediates It has gradually become the focus and core of the development of the chemical industry in various countries. With the gradual recovery of the global economy, the continuous growth of the total population and the improvement of the aging society, the scale of the global pharmaceutical market has maintained a steady growth. From the perspective of the terminal market, the current global market size of antibiotic preparations is about 50 billion US dollars. Antibiotic products and markets are relatively mature, but due to the rigid demand for antibiotics in clinical treatment, the industry still shows a low growth trend.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cephalosporin Intermediates market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Antibioticos S.P.A.
Biochemie
DSM
CordenPharma
Dragon Phama
Nectar Lifesciences
CSPC Pharmaceutical Group
Yili Chuanning Biotechnology
Joincare Pharmaceutical Group
Jiangsu Weiqida Pharmaceutical
North China Pharmaceutical
Shanghai Shyndec Pharmaceuti
Shandong Jincheng Pharmaceutical Group
Hebei Hejia Pharmaceutical Technology Group
Segment by Type
7-ACA
D-7ACA
7-ADCA

Segment by Application


Ceftazidime
Ceftriaxone
Cefalexin
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cephalosporin Intermediates market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cephalosporin Intermediates, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cephalosporin Intermediates industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cephalosporin Intermediates in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cephalosporin Intermediates introduction, etc. Cephalosporin Intermediates Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Cephalosporin Intermediates market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Cephalosporin Intermediates Market Overview
1.1 Cephalosporin Intermediates Product Overview
1.2 Cephalosporin Intermediates Market Segment by Type
1.2.1 7-ACA
1.2.2 D-7ACA
1.2.3 7-ADCA
1.3 Global Cephalosporin Intermediates Market Size by Type
1.3.1 Global Cephalosporin Intermediates Market Size Overview by Type (2018-2029)
1.3.2 Global Cephalosporin Intermediates Historic Market Size Review by Type (2018-2024)
1.3.3 Global Cephalosporin Intermediates Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cephalosporin Intermediates Sales Breakdown by Type (2018-2024)
1.4.2 Europe Cephalosporin Intermediates Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Cephalosporin Intermediates Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Cephalosporin Intermediates Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Cephalosporin Intermediates Sales Breakdown by Type (2018-2024)
2 Global Cephalosporin Intermediates Market Competition by Company
2.1 Global Top Players by Cephalosporin Intermediates Sales (2018-2024)
2.2 Global Top Players by Cephalosporin Intermediates Revenue (2018-2024)
2.3 Global Top Players by Cephalosporin Intermediates Price (2018-2024)
2.4 Global Top Manufacturers Cephalosporin Intermediates Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cephalosporin Intermediates Market Competitive Situation and Trends
2.5.1 Cephalosporin Intermediates Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Cephalosporin Intermediates Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cephalosporin Intermediates as of 2022)
2.7 Date of Key Manufacturers Enter into Cephalosporin Intermediates Market
2.8 Key Manufacturers Cephalosporin Intermediates Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cephalosporin Intermediates Status and Outlook by Region
3.1 Global Cephalosporin Intermediates Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cephalosporin Intermediates Historic Market Size by Region
3.2.1 Global Cephalosporin Intermediates Sales in Volume by Region (2018-2024)
3.2.2 Global Cephalosporin Intermediates Sales in Value by Region (2018-2024)
3.2.3 Global Cephalosporin Intermediates Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Cephalosporin Intermediates Forecasted Market Size by Region
3.3.1 Global Cephalosporin Intermediates Sales in Volume by Region (2024-2029)
3.3.2 Global Cephalosporin Intermediates Sales in Value by Region (2024-2029)
3.3.3 Global Cephalosporin Intermediates Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cephalosporin Intermediates by Application
4.1 Cephalosporin Intermediates Market Segment by Application
4.1.1 Ceftazidime
4.1.2 Ceftriaxone
4.1.3 Cefalexin
4.1.4 Others
4.2 Global Cephalosporin Intermediates Market Size by Application
4.2.1 Global Cephalosporin Intermediates Market Size Overview by Application (2018-2029)
4.2.2 Global Cephalosporin Intermediates Historic Market Size Review by Application (2018-2024)
4.2.3 Global Cephalosporin Intermediates Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cephalosporin Intermediates Sales Breakdown by Application (2018-2024)
4.3.2 Europe Cephalosporin Intermediates Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Cephalosporin Intermediates Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Cephalosporin Intermediates Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Cephalosporin Intermediates Sales Breakdown by Application (2018-2024)
5 North America Cephalosporin Intermediates by Country
5.1 North America Cephalosporin Intermediates Historic Market Size by Country
5.1.1 North America Cephalosporin Intermediates Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cephalosporin Intermediates Sales in Volume by Country (2018-2024)
5.1.3 North America Cephalosporin Intermediates Sales in Value by Country (2018-2024)
5.2 North America Cephalosporin Intermediates Forecasted Market Size by Country
5.2.1 North America Cephalosporin Intermediates Sales in Volume by Country (2024-2029)
5.2.2 North America Cephalosporin Intermediates Sales in Value by Country (2024-2029)
6 Europe Cephalosporin Intermediates by Country
6.1 Europe Cephalosporin Intermediates Historic Market Size by Country
6.1.1 Europe Cephalosporin Intermediates Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cephalosporin Intermediates Sales in Volume by Country (2018-2024)
6.1.3 Europe Cephalosporin Intermediates Sales in Value by Country (2018-2024)
6.2 Europe Cephalosporin Intermediates Forecasted Market Size by Country
6.2.1 Europe Cephalosporin Intermediates Sales in Volume by Country (2024-2029)
6.2.2 Europe Cephalosporin Intermediates Sales in Value by Country (2024-2029)
7 Asia-Pacific Cephalosporin Intermediates by Region
7.1 Asia-Pacific Cephalosporin Intermediates Historic Market Size by Region
7.1.1 Asia-Pacific Cephalosporin Intermediates Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cephalosporin Intermediates Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Cephalosporin Intermediates Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Cephalosporin Intermediates Forecasted Market Size by Region
7.2.1 Asia-Pacific Cephalosporin Intermediates Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cephalosporin Intermediates Sales in Value by Region (2024-2029)
8 Latin America Cephalosporin Intermediates by Country
8.1 Latin America Cephalosporin Intermediates Historic Market Size by Country
8.1.1 Latin America Cephalosporin Intermediates Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cephalosporin Intermediates Sales in Volume by Country (2018-2024)
8.1.3 Latin America Cephalosporin Intermediates Sales in Value by Country (2018-2024)
8.2 Latin America Cephalosporin Intermediates Forecasted Market Size by Country
8.2.1 Latin America Cephalosporin Intermediates Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cephalosporin Intermediates Sales in Value by Country (2024-2029)
9 Middle East and Africa Cephalosporin Intermediates by Country
9.1 Middle East and Africa Cephalosporin Intermediates Historic Market Size by Country
9.1.1 Middle East and Africa Cephalosporin Intermediates Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cephalosporin Intermediates Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Cephalosporin Intermediates Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Cephalosporin Intermediates Forecasted Market Size by Country
9.2.1 Middle East and Africa Cephalosporin Intermediates Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cephalosporin Intermediates Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Antibioticos S.P.A.
10.1.1 Antibioticos S.P.A. Company Information
10.1.2 Antibioticos S.P.A. Introduction and Business Overview
10.1.3 Antibioticos S.P.A. Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Antibioticos S.P.A. Cephalosporin Intermediates Products Offered
10.1.5 Antibioticos S.P.A. Recent Development
10.2 Biochemie
10.2.1 Biochemie Company Information
10.2.2 Biochemie Introduction and Business Overview
10.2.3 Biochemie Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Biochemie Cephalosporin Intermediates Products Offered
10.2.5 Biochemie Recent Development
10.3 DSM
10.3.1 DSM Company Information
10.3.2 DSM Introduction and Business Overview
10.3.3 DSM Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.3.4 DSM Cephalosporin Intermediates Products Offered
10.3.5 DSM Recent Development
10.4 CordenPharma
10.4.1 CordenPharma Company Information
10.4.2 CordenPharma Introduction and Business Overview
10.4.3 CordenPharma Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.4.4 CordenPharma Cephalosporin Intermediates Products Offered
10.4.5 CordenPharma Recent Development
10.5 Dragon Phama
10.5.1 Dragon Phama Company Information
10.5.2 Dragon Phama Introduction and Business Overview
10.5.3 Dragon Phama Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Dragon Phama Cephalosporin Intermediates Products Offered
10.5.5 Dragon Phama Recent Development
10.6 Nectar Lifesciences
10.6.1 Nectar Lifesciences Company Information
10.6.2 Nectar Lifesciences Introduction and Business Overview
10.6.3 Nectar Lifesciences Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Nectar Lifesciences Cephalosporin Intermediates Products Offered
10.6.5 Nectar Lifesciences Recent Development
10.7 CSPC Pharmaceutical Group
10.7.1 CSPC Pharmaceutical Group Company Information
10.7.2 CSPC Pharmaceutical Group Introduction and Business Overview
10.7.3 CSPC Pharmaceutical Group Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.7.4 CSPC Pharmaceutical Group Cephalosporin Intermediates Products Offered
10.7.5 CSPC Pharmaceutical Group Recent Development
10.8 Yili Chuanning Biotechnology
10.8.1 Yili Chuanning Biotechnology Company Information
10.8.2 Yili Chuanning Biotechnology Introduction and Business Overview
10.8.3 Yili Chuanning Biotechnology Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Yili Chuanning Biotechnology Cephalosporin Intermediates Products Offered
10.8.5 Yili Chuanning Biotechnology Recent Development
10.9 Joincare Pharmaceutical Group
10.9.1 Joincare Pharmaceutical Group Company Information
10.9.2 Joincare Pharmaceutical Group Introduction and Business Overview
10.9.3 Joincare Pharmaceutical Group Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Joincare Pharmaceutical Group Cephalosporin Intermediates Products Offered
10.9.5 Joincare Pharmaceutical Group Recent Development
10.10 Jiangsu Weiqida Pharmaceutical
10.10.1 Jiangsu Weiqida Pharmaceutical Company Information
10.10.2 Jiangsu Weiqida Pharmaceutical Introduction and Business Overview
10.10.3 Jiangsu Weiqida Pharmaceutical Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Jiangsu Weiqida Pharmaceutical Cephalosporin Intermediates Products Offered
10.10.5 Jiangsu Weiqida Pharmaceutical Recent Development
10.11 North China Pharmaceutical
10.11.1 North China Pharmaceutical Company Information
10.11.2 North China Pharmaceutical Introduction and Business Overview
10.11.3 North China Pharmaceutical Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.11.4 North China Pharmaceutical Cephalosporin Intermediates Products Offered
10.11.5 North China Pharmaceutical Recent Development
10.12 Shanghai Shyndec Pharmaceuti
10.12.1 Shanghai Shyndec Pharmaceuti Company Information
10.12.2 Shanghai Shyndec Pharmaceuti Introduction and Business Overview
10.12.3 Shanghai Shyndec Pharmaceuti Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Shanghai Shyndec Pharmaceuti Cephalosporin Intermediates Products Offered
10.12.5 Shanghai Shyndec Pharmaceuti Recent Development
10.13 Shandong Jincheng Pharmaceutical Group
10.13.1 Shandong Jincheng Pharmaceutical Group Company Information
10.13.2 Shandong Jincheng Pharmaceutical Group Introduction and Business Overview
10.13.3 Shandong Jincheng Pharmaceutical Group Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Shandong Jincheng Pharmaceutical Group Cephalosporin Intermediates Products Offered
10.13.5 Shandong Jincheng Pharmaceutical Group Recent Development
10.14 Hebei Hejia Pharmaceutical Technology Group
10.14.1 Hebei Hejia Pharmaceutical Technology Group Company Information
10.14.2 Hebei Hejia Pharmaceutical Technology Group Introduction and Business Overview
10.14.3 Hebei Hejia Pharmaceutical Technology Group Cephalosporin Intermediates Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Hebei Hejia Pharmaceutical Technology Group Cephalosporin Intermediates Products Offered
10.14.5 Hebei Hejia Pharmaceutical Technology Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cephalosporin Intermediates Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cephalosporin Intermediates Industrial Chain Analysis
11.4 Cephalosporin Intermediates Market Dynamics
11.4.1 Cephalosporin Intermediates Industry Trends
11.4.2 Cephalosporin Intermediates Market Drivers
11.4.3 Cephalosporin Intermediates Market Challenges
11.4.4 Cephalosporin Intermediates Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cephalosporin Intermediates Distributors
12.3 Cephalosporin Intermediates Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 7-ACA
Table 2. Major Company of D-7ACA
Table 3. Major Company of 7-ADCA
Table 4. Global Cephalosporin Intermediates Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Cephalosporin Intermediates Sales by Type (2018-2024) & (K Units)
Table 6. Global Cephalosporin Intermediates Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Cephalosporin Intermediates Sales by Type (2018-2024) & (US& Million)
Table 8. Global Cephalosporin Intermediates Market Share in Value by Type (2018-2024)
Table 9. Global Cephalosporin Intermediates Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Cephalosporin Intermediates Sales by Type (2024-2029) & (K Units)
Table 11. Global Cephalosporin Intermediates Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Cephalosporin Intermediates Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Cephalosporin Intermediates Sales Market Share in Value by Type (2024-2029)
Table 14. Global Cephalosporin Intermediates Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Cephalosporin Intermediates Sales by Type (2018-2024) & (K Units)
Table 16. North America Cephalosporin Intermediates Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Cephalosporin Intermediates Sales (K Units) by Type (2018-2024)
Table 18. Europe Cephalosporin Intermediates Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Cephalosporin Intermediates Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Cephalosporin Intermediates Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Cephalosporin Intermediates Sales (K Units) by Type (2018-2024)
Table 22. Latin America Cephalosporin Intermediates Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Cephalosporin Intermediates Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Cephalosporin Intermediates Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Cephalosporin Intermediates Sales by Company (2018-2024) & (K Units)
Table 26. Global Cephalosporin Intermediates Sales Share by Company (2018-2024)
Table 27. Global Cephalosporin Intermediates Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Cephalosporin Intermediates Revenue Share by Company (2018-2024)
Table 29. Global Market Cephalosporin Intermediates Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Cephalosporin Intermediates Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Cephalosporin Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cephalosporin Intermediates as of 2022)
Table 33. Date of Key Manufacturers Enter into Cephalosporin Intermediates Market
Table 34. Key Manufacturers Cephalosporin Intermediates Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Cephalosporin Intermediates Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Cephalosporin Intermediates Sales by Region (2018-2024) & (K Units)
Table 38. Global Cephalosporin Intermediates Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Cephalosporin Intermediates Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Cephalosporin Intermediates Sales Market Share in Value by Region (2018-2024)
Table 41. Global Cephalosporin Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Cephalosporin Intermediates Sales by Region (2024-2029) & (K Units)
Table 43. Global Cephalosporin Intermediates Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Cephalosporin Intermediates Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Cephalosporin Intermediates Sales Market Share in Value by Region (2024-2029)
Table 46. Global Cephalosporin Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Cephalosporin Intermediates Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Cephalosporin Intermediates Sales by Application (2018-2024) & (K Units)
Table 49. Global Cephalosporin Intermediates Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Cephalosporin Intermediates Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Cephalosporin Intermediates Sales Market Share in Value by Application (2018-2024)
Table 52. Global Cephalosporin Intermediates Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Cephalosporin Intermediates Sales by Application (2024-2029) & (K Units)
Table 54. Global Cephalosporin Intermediates Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Cephalosporin Intermediates Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Cephalosporin Intermediates Sales Market Share in Value by Application (2024-2029)
Table 57. Global Cephalosporin Intermediates Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Cephalosporin Intermediates Sales by Application (2018-2024) (K Units)
Table 59. North America Cephalosporin Intermediates Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Cephalosporin Intermediates Sales by Application (2018-2024) (K Units)
Table 61. Europe Cephalosporin Intermediates Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Cephalosporin Intermediates Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Cephalosporin Intermediates Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Cephalosporin Intermediates Sales by Application (2018-2024) (K Units)
Table 65. Latin America Cephalosporin Intermediates Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Cephalosporin Intermediates Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Cephalosporin Intermediates Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Cephalosporin Intermediates Sales by Country (2018-2024) & (K Units)
Table 69. North America Cephalosporin Intermediates Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Cephalosporin Intermediates Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Cephalosporin Intermediates Sales Market Share in Value by Country (2018-2024)
Table 72. North America Cephalosporin Intermediates Sales by Country (2024-2029) & (K Units)
Table 73. North America Cephalosporin Intermediates Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Cephalosporin Intermediates Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Cephalosporin Intermediates Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Cephalosporin Intermediates Sales by Country (2018-2024) & (K Units)
Table 77. Europe Cephalosporin Intermediates Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Cephalosporin Intermediates Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Cephalosporin Intermediates Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Cephalosporin Intermediates Sales by Country (2024-2029) & (K Units)
Table 81. Europe Cephalosporin Intermediates Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Cephalosporin Intermediates Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Cephalosporin Intermediates Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Cephalosporin Intermediates Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Cephalosporin Intermediates Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Cephalosporin Intermediates Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Cephalosporin Intermediates Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Cephalosporin Intermediates Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Cephalosporin Intermediates Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Cephalosporin Intermediates Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Cephalosporin Intermediates Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Cephalosporin Intermediates Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Cephalosporin Intermediates Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Cephalosporin Intermediates Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Cephalosporin Intermediates Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Cephalosporin Intermediates Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Cephalosporin Intermediates Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Cephalosporin Intermediates Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Cephalosporin Intermediates Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Cephalosporin Intermediates Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Cephalosporin Intermediates Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Cephalosporin Intermediates Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Cephalosporin Intermediates Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Cephalosporin Intermediates Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Cephalosporin Intermediates Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Cephalosporin Intermediates Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Cephalosporin Intermediates Sales Market Share in Value by Country (2024-2029)
Table 108. Antibioticos S.P.A. Company Information
Table 109. Antibioticos S.P.A. Introduction and Business Overview
Table 110. Antibioticos S.P.A. Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Antibioticos S.P.A. Cephalosporin Intermediates Product
Table 112. Antibioticos S.P.A. Recent Development
Table 113. Biochemie Company Information
Table 114. Biochemie Introduction and Business Overview
Table 115. Biochemie Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Biochemie Cephalosporin Intermediates Product
Table 117. Biochemie Recent Development
Table 118. DSM Company Information
Table 119. DSM Introduction and Business Overview
Table 120. DSM Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. DSM Cephalosporin Intermediates Product
Table 122. DSM Recent Development
Table 123. CordenPharma Company Information
Table 124. CordenPharma Introduction and Business Overview
Table 125. CordenPharma Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. CordenPharma Cephalosporin Intermediates Product
Table 127. CordenPharma Recent Development
Table 128. Dragon Phama Company Information
Table 129. Dragon Phama Introduction and Business Overview
Table 130. Dragon Phama Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Dragon Phama Cephalosporin Intermediates Product
Table 132. Dragon Phama Recent Development
Table 133. Nectar Lifesciences Company Information
Table 134. Nectar Lifesciences Introduction and Business Overview
Table 135. Nectar Lifesciences Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Nectar Lifesciences Cephalosporin Intermediates Product
Table 137. Nectar Lifesciences Recent Development
Table 138. CSPC Pharmaceutical Group Company Information
Table 139. CSPC Pharmaceutical Group Introduction and Business Overview
Table 140. CSPC Pharmaceutical Group Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. CSPC Pharmaceutical Group Cephalosporin Intermediates Product
Table 142. CSPC Pharmaceutical Group Recent Development
Table 143. Yili Chuanning Biotechnology Company Information
Table 144. Yili Chuanning Biotechnology Introduction and Business Overview
Table 145. Yili Chuanning Biotechnology Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Yili Chuanning Biotechnology Cephalosporin Intermediates Product
Table 147. Yili Chuanning Biotechnology Recent Development
Table 148. Joincare Pharmaceutical Group Company Information
Table 149. Joincare Pharmaceutical Group Introduction and Business Overview
Table 150. Joincare Pharmaceutical Group Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Joincare Pharmaceutical Group Cephalosporin Intermediates Product
Table 152. Joincare Pharmaceutical Group Recent Development
Table 153. Jiangsu Weiqida Pharmaceutical Company Information
Table 154. Jiangsu Weiqida Pharmaceutical Introduction and Business Overview
Table 155. Jiangsu Weiqida Pharmaceutical Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Jiangsu Weiqida Pharmaceutical Cephalosporin Intermediates Product
Table 157. Jiangsu Weiqida Pharmaceutical Recent Development
Table 158. North China Pharmaceutical Company Information
Table 159. North China Pharmaceutical Introduction and Business Overview
Table 160. North China Pharmaceutical Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. North China Pharmaceutical Cephalosporin Intermediates Product
Table 162. North China Pharmaceutical Recent Development
Table 163. Shanghai Shyndec Pharmaceuti Company Information
Table 164. Shanghai Shyndec Pharmaceuti Introduction and Business Overview
Table 165. Shanghai Shyndec Pharmaceuti Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Shanghai Shyndec Pharmaceuti Cephalosporin Intermediates Product
Table 167. Shanghai Shyndec Pharmaceuti Recent Development
Table 168. Shandong Jincheng Pharmaceutical Group Company Information
Table 169. Shandong Jincheng Pharmaceutical Group Introduction and Business Overview
Table 170. Shandong Jincheng Pharmaceutical Group Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Shandong Jincheng Pharmaceutical Group Cephalosporin Intermediates Product
Table 172. Shandong Jincheng Pharmaceutical Group Recent Development
Table 173. Hebei Hejia Pharmaceutical Technology Group Company Information
Table 174. Hebei Hejia Pharmaceutical Technology Group Introduction and Business Overview
Table 175. Hebei Hejia Pharmaceutical Technology Group Cephalosporin Intermediates Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Hebei Hejia Pharmaceutical Technology Group Cephalosporin Intermediates Product
Table 177. Hebei Hejia Pharmaceutical Technology Group Recent Development
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Cephalosporin Intermediates Market Trends
Table 181. Cephalosporin Intermediates Market Drivers
Table 182. Cephalosporin Intermediates Market Challenges
Table 183. Cephalosporin Intermediates Market Restraints
Table 184. Cephalosporin Intermediates Distributors List
Table 185. Cephalosporin Intermediates Downstream Customers
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Cephalosporin Intermediates Product Picture
Figure 2. Global Cephalosporin Intermediates Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Cephalosporin Intermediates Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Cephalosporin Intermediates Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 7-ACA
Figure 6. Global 7-ACA Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of D-7ACA
Figure 8. Global D-7ACA Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of 7-ADCA
Figure 10. Global 7-ADCA Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Cephalosporin Intermediates Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Cephalosporin Intermediates Sales Market Share by Type in 2022 & 2029
Figure 13. North America Cephalosporin Intermediates Sales Market Share in Volume by Type in 2022
Figure 14. North America Cephalosporin Intermediates Sales Market Share in Value by Type in 2022
Figure 15. Europe Cephalosporin Intermediates Sales Market Share in Volume by Type in 2022
Figure 16. Europe Cephalosporin Intermediates Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Cephalosporin Intermediates Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Cephalosporin Intermediates Sales Market Share in Value by Type in 2022
Figure 19. Latin America Cephalosporin Intermediates Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Cephalosporin Intermediates Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Cephalosporin Intermediates Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Cephalosporin Intermediates Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Cephalosporin Intermediates Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Cephalosporin Intermediates Revenue in 2022
Figure 25. Cephalosporin Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Ceftazidime
Figure 27. Global Ceftazidime Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Ceftriaxone
Figure 29. Global Ceftriaxone Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Cefalexin
Figure 31. Global Cefalexin Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Cephalosporin Intermediates Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Cephalosporin Intermediates Sales Market Share by Application in 2022 & 2029
Figure 36. North America Cephalosporin Intermediates Sales Market Share in Volume by Application in 2022
Figure 37. North America Cephalosporin Intermediates Sales Market Share in Value by Application in 2022
Figure 38. Europe Cephalosporin Intermediates Sales Market Share in Volume by Application in 2022
Figure 39. Europe Cephalosporin Intermediates Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Cephalosporin Intermediates Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Cephalosporin Intermediates Sales Market Share in Value by Application in 2022
Figure 42. Latin America Cephalosporin Intermediates Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Cephalosporin Intermediates Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Cephalosporin Intermediates Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Cephalosporin Intermediates Manufacturing Cost Structure
Figure 47. Cephalosporin Intermediates Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries